2,6,10,14-四甲基十五烷酸 | 1189-37-3

• 物质功能分类: 分析化学 - 食品安全 - 脂肪酸、脂肪酸甲酯
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 2,6,10,14-四甲基十五烷酸
• 中文别名: 降脂(植)烷酸
• 英文名称: 2,6,10,14-Tetramethyl-pentadecansaeure
• 英文别名: pristanic acid；Pristansaeure；2,6,10,14-tetramethylpentadecanoic acid
• CAS: 1189-37-3
• 化学式: C₁₉H₃₈O₂
• 分子量: 298.51
• InChiKey: PAHGJZDQXIOYTH-UHFFFAOYSA-N

物化性质

• 沸点：
  408.0±13.0 °C(Predicted)
• 密度：
  0.882±0.06 g/cm3(Predicted)
• 闪点：
  14 °C
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）
• 物理描述：
  Solid
• 碰撞截面：
  206.3 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]

计算性质

• 辛醇/水分配系数(LogP)：
  8
• 重原子数：
  21
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  F
• 安全说明：
  S7
• 危险类别码：
  R11
• WGK Germany：
  1
• 危险标志：
  GHS02,GHS07
• 危险品运输编号：
  UN 1170 3/PG 2
• 危险性描述：
  H225,H319
• 危险性防范说明：
  P210,P280,P305 + P351 + P338,P337 + P313,P403 + P235

反应信息

• 作为产物：
  描述：

  植烷酸 在 sodium azide 、 硫酸 作用下， 以 氯仿 为溶剂， 生成 2,6,10,14-四甲基十五烷酸
  参考文献：
  名称：

  Eldjarn; Jellum; Aas, Acta Chemica Scandinavica (1947), 1966, vol. 20, # 8, p. 2313 - 2314

  摘要：

  DOI：

文献信息

• BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS
  申请人：Dietz Ulrich

  公开号：US20140099354A1

  公开（公告）日：2014-04-10

  The present invention relates to nitro-carboxylic acid (s)-containing phospholipids, to be used for coating of medical devices such as stents, catheter balloons, wound pads or surgical suture material and for bio-passivating compositions, such as rinses, waterproofing solutions, coating solutions, cryoprotection solutions, cold preservation media, lyoprotection solutions, contrast media solutions, preservation and reperfusion solutions containing these compounds as well as preparing solutions thereof and coating medical devices as well as their uses.

  本发明涉及一种含硝基羧酸（s）的磷脂，用于涂覆医疗器械，如支架、导管球囊、伤口垫或外科缝合材料，以及用于生物钝化组合物，如漱口液、防水溶液、涂层溶液、冷冻保护溶液、冷藏介质、冻干保护溶液、造影介质溶液、含有这些化合物的保存和再灌注溶液，以及制备这些溶液和涂覆医疗器械以及它们的用途。
• [EN] ANTIBIOFILM FORMULATIONS<br/>[FR] FORMULATIONS D'ANTIBIOFILM
  申请人：UNIV NORTHERN ARIZONA

  公开号：WO2018222924A1

  公开（公告）日：2018-12-06

  Methods and compositions related to molecules and formulations comprising antibiofilm materials are provide, including new formulations of Deep Eutectic Solvents (DES) that are chemically related to choline geranate. Specifically, geranic acid (a component of choline geranate DES) is a molecule from the isoprenoid/terpene family of compounds. Other members of this family as DES components include isoprenoid acids and chemical derivatives thereof.

  提供与分子和配方相关的方法和组合物，其中包括含有抗生物膜材料的新配方，其中这些配方包括与胆碱油酸盐化物相关的新型深共熔溶剂（DES）。具体来说，油酸（胆碱油酸盐化物DES的一种成分）是异戊二烯/萜类化合物家族中的一种分子。该家族的其他成员作为DES组分包括异戊二烯酸及其化学衍生物。
• METHODS (AMACR)
  申请人：UNIVERSITY OF BATH

  公开号：US20170176436A1

  公开（公告）日：2017-06-22

  A method of measuring α-methylacyl-CoA racemase (AMACR) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said AMACR to produce a product compound having an additional carbon-carbon double bond; and (iii) measuring the amount of said leaving group and/or of said product compound and/or of unreacted substrate compound. Also provided are methods of diagnosis and medical imaging, in particular for use in diagnosing prostate cancer. Also provided are substrate compounds of Formula 1 for use in the methods described herein.

  描述了一种测量样本中α-甲基酰辅酶A羧化酶（AMACR）活性的方法，包括以下步骤：（i）提供样本；（ii）将所述样本与底物化合物接触，该化合物经过由所述AMACR催化的氢和一个离去基团的消除产生具有额外碳-碳双键的产物化合物；以及（iii）测量所述离去基团和/或所述产物化合物和/或未反应的底物化合物的量。还提供了诊断和医学成像的方法，特别用于诊断前列腺癌。还提供了用于上述方法的Formula 1的底物化合物。
• METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND
  申请人：Komiyama Masato

  公开号：US20130158272A1

  公开（公告）日：2013-06-20

  The present invention provides a method for producing a xanthine oxidase inhibitor, which is a therapeutic agent for hyperuricemia, or intermediates of the same, said method being efficient and using a short process. The present invention is a novel coupling method for obtaining a compound represented by formula (3) by bringing about a coupling reaction between a compound represented by formula (1) and a compound represented by formula (2), in the presence of a palladium compound, a ligand capable of coordinating to the palladium compound, a base, a C 1 -C 40 carboxylic acid, and at least one kind of additive.

  本发明提供了一种生产黄嘌呤氧化酶抑制剂的方法，该抑制剂是治疗高尿酸血症的药物，或者其中间体，该方法高效且使用流程简短。本发明是一种新型耦合方法，通过在钯化合物、能够配位到钯化合物的配体、碱、C1-C40羧酸和至少一种添加剂的存在下，在式（1）所代表的化合物和式（2）所代表的化合物之间引发耦合反应，从而获得式（3）所代表的化合物。
• COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
  申请人：Gjorstrup Per

  公开号：US20110190242A1

  公开（公告）日：2011-08-04

  The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound.

  该发明涉及治疗炎症性疾病的方法，包括给予公式A的化合物、任何一个公式1-49或I-III的化合物、脂氧素化合物或氧脂素化合物。